Copeptin as a Biomarker of Atherosclerosis in Type 1 Diabetic Patients

AIM: To evaluate copeptin as an early marker of atherosclerosis in adolescent type 1 diabetics. METHODS: Sixty-two type 1 diabetic patients and 50 healthy volunteers were enrolled in the study. Serum copeptin, glycosylated haemoglobin (HbA1c), lipid profile, oxidised low-density lipoprotein (OxLDL),...

Descripción completa

Detalles Bibliográficos
Autores principales: El Dayem, Soha M. Abd, Battah, Ahmed A., El Bohy, Abo El Magd, Yousef, Rasha Nazih, Talaat, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2020
Materias:
Clinical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061391/
https://www.ncbi.nlm.nih.gov/pubmed/33318769
http://dx.doi.org/10.3889/oamjms.2019.643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061391/
https://www.ncbi.nlm.nih.gov/pubmed/33318769
http://dx.doi.org/10.3889/oamjms.2019.643

Ejemplares similares